Publication Procedure. On completion of the Trial and evaluation of the results, or abandonment of the Trial, respectively, the Institution or an Investigator may publish or otherwise publicly disclose the results of the Trial or the treatment of any Subject participating in the Trial for internal research and educational purposes, subject, however, to the following conditions and compliance with Section 7(c) above:
Publication Procedure. The default arrangement is “assumed permission”. If the publishing party does not receive a written objection from the reviewing party within [45]/[60]/[90] days of submission of notification of publication then permission to publish will be deemed to have been given. The ZonMw Terms and Conditions Governing Grants of ZonMw allows for a maximum period of 90 days. Example
Publication Procedure. On completion of the Trial and evaluation of the results, or abandonment of the Trial, respectively, the Institution or an Investigator may publish or otherwise publicly disclose the results of the Trial or the treatment of any Subject participating in the Trial for internal research and educational purposes, subject, however, to the following conditions and compliance with Section 7(c) above: (a) Postup při publikování. Po dokončení Klinického hodnocení a vyhodnocení výsledků nebo po upuštění od Klinického hodnocení mohou Zdravotnické zařízení nebo Zkoušející publikovat nebo jinak zveřejnit výsledky Klinického hodnocení nebo léčby kteréhokoliv Subjektu zapojeného do Klinického hodnocení pro účely interního výzkumu a vzdělávání, nicméně musí při tom být dodrženy následující podmínky a požadavky čl. 7(c) výše:
Publication Procedure. Institution agrees to submit any proposed disclosure, publication or presentation to Sponsor for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation/disclosure. Within thirty (30) days of its receipt, Sponsor shall advise Institution in writing of any information contained therein which is Confidential Information (other than Study Data) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution as applicable, to remove specifically identified Confidential Information (other than Study Data) and/or to delay the proposed publication or presentation for an additional one hundred and fifty (150) days to enable Sponsor to seek patent protection for Inventions. Nothing in this Section 5.3 shall be construed as enabling or authorizing Institution to disclose Confidential Information without Sponsor’s prior written consent in each case, even if such information was furnished to Institution by or on behalf of Sponsor in connection with the Study. If the Parties disagree concerning the accuracy and appropriateness of the data analysis and presentation, or whether certain information is part of Sponsor’s “Confidential Information”, the Parties shall meet and discuss the matter in good faith to attempt to amicably resolve the dispute. 5.4Media Contacts Institution shall not, and shall ensure that Institution’s Study Staff do not engage in interviews or other contacts with the media, including but not limited to newspapers, radio, television and the Internet, related to the Study, the Investigational Product, Inventions, or Study Data without the prior jakékoli třetí straně či nezveřejní jakákoli Studijní data či údaje jakékoli třetí straně, a to v rozsahu větším, nežli v jakém mohou být odhaleny, zveřejněny, zpřístupněny či sděleny v jakékoli publikaci, prezentaci či jiném odhalení na základě odstavce 5.1. 5.3 Postup při publikování Zdravotnické zařízení se zavazuje předložit jakékoli zveřejňované údaje, publikaci nebo prezentaci ke kontrole Zadavateli nejméně šedesát (60) dnů před předložením jakékoli takové navrhované publikace vydavateli nebo uskutečněním takové navrhované prezentace / zveřejnění údajů. Ve lhůtě třiceti (30) dnů od obdržení tohoto materiálu Zadavatel písemně vyrozumí Zdravotnické zařízení o jakýchkoli informacích obsažených v tomto materiálu, které představují Důvěrné informace (odlišné od St...
Publication Procedure. On completion of
Publication Procedure. At the end of the research, the publishable part of the Results will be described in the final report as defined under section 4.4.3. Review of publications Any publication or communication, whether written or oral, in connection with Result is required to be submitted to the Collaborative Board. To this end, the full text of the proposed publication or communication shall be submitted to the Collaborative Board. If the Collaborative Research Project has established a secure web site, then the full text can be submitted through it. Each member of the Collaborative Board will have the possibility to appoint one or several internal expert(s) to assess the content of the publication. Each member of the Collaborative Board will have one (1) calendar month from the date of submission of the publication to object to it in writing to the Chair. Beyond this period, if no objection has been received consent shall be deemed to have been given. This obligation, nonetheless, should not prevent the application of a Patent in accordance with the provisions of this Consortium Agreement, nor should it unnecessarily prevent a possible commercial use.
Publication Procedure. Institution agrees to submit any proposed disclosure, publication or presentation to Sponsor for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation/disclosure. Within thirty (30) days of its receipt, Sponsor shall advise Institution in writing of any information contained therein which is Confidential Information (other than Study Data) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution as applicable, to remove specifically identified Confidential Information (other than Study Data) and/or to delay the proposed publication or presentation for an additional one hundred and fifty (150) days to enable Sponsor to seek patent protection for Inventions. Nothing in this Section 5.3 shall be construed as enabling or authorizing Institution to předčasnému ukončení Studie, Poskytovatel zdravotních služeb bude oprávněn publikovat a prezentovat výsledky činnosti Poskytovatele zdravotních služeb, jež je prováděna na základě této Smlouvy, a to včetně Studijních dat a údajů, výhradně v souladu s podmínkami stanovenými v odstavci 5.3 „Postup při publikování“. 5.2
Publication Procedure. The Parties agree the following publication procedure. A copy of any proposed publication in connection with or relating to the Project shall be sent to the Coordinator and to the concerned Party(ies) at the earliest time possible. Any objection to the planned publication shall be made in accordance with the GA in writing to the Coordinator and to any party concerned within thirty (30) days after receipt of the notice. If no objection is made within the time limit stated above, the publication is permitted. An objection is justified if: ▪ the protection of the objecting Party’s Foreground or Background is adversely affected; ▪ the proposed publication includes Confidential Information of the objecting Party or of the Consortium as a whole; ▪ the publication of such information contrasts the academic or commercial interests of the objecting Party. The objection has to include a precise request for necessary modifications. In the event that an objection is raised on any of the above defined grounds and within the above period of thirty (30) days, the Party proposing the publication and the Party objecting shall seek in:
Publication Procedure to ensure that the
Publication Procedure. When a Party plans to publish the results of the studies conducted in the course of the development in and outside Territory, such Party shall submit the draft of the publication, translated into English, to the other Party at least six (6) weeks prior to the planned submission for publication for approval. Any such publication shall need the other Party’s prior written consent, which shall not be unreasonably withheld. Any comment, reasonable request for modification, or reasonable rejection must be made within four (4) weeks from receipt of the draft. Thereafter, the draft is deemed to be approved. However, for the elimination of any doubt, CONFORMA will have the sole right to decide upon its own publication strategy in the Territory.
